Evaluation of Population Pharmacokinetic Models of Micafungin: Implications for Dosing Regimen Optimization in Critically Ill Patients
Micafungin (MFG) is a widely used echinocandin antifungal agent for treating invasive candidiasis, particularly in critically ill patients. However, its pharmacokinetics can be highly variable in this population. This systematic review aims to summarize population pharmacokinetic models and provide...
Saved in:
| Main Authors: | Xiping Li, Xiaoqin Liu, Juehui Mao, Dong Liu, Zheng Jiao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-08-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/16/9/1145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL AND PHARMACOLOGICAL APPROACHES TO OPTIMIZE THE DOSING REGIMEN OF ANTIBACTERIAL DRUGS IN PEDIATRICS
by: Natal’ya B. Lazareva, et al.
Published: (2018-04-01) -
Dosing Regimen Recommendations for Sirolimus in Adult Liver Transplant Recipients: Insights from a Population Pharmacokinetic Model
by: Mao J, et al.
Published: (2024-12-01) -
Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies
by: Luisa Oliveira Santos, et al.
Published: (2024-08-01) -
Are plasma drug concentrations still necessary? Rethinking the pharmacokinetic link in dose–response relationships
by: Nicolas Simon, et al.
Published: (2025-07-01) -
Optimization of meropenem dosing regimens in critically ill patients with augmented renal clearance
by: Jinfeng Luo, et al.
Published: (2025-05-01)